Therefore, our results indicate that lactate secreted by PKM2 significantly promotes Galectin-9-mediated immunosuppression through NF-κB pathway inhibition, which bridges metabolites with immunosuppression and indicates a promising therapeutic target in HNSCC. This evidence concerns the gene PKM and head and neck squamous cell carcinoma.